PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 15 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $36,000 | -88.0% | 2,000,000 | 0.0% | 0.00% | -90.6% |
| Q4 2018 | $300,000 | -57.1% | 2,000,000 | 0.0% | 0.03% | -47.5% |
| Q3 2018 | $700,000 | -12.5% | 2,000,000 | 0.0% | 0.06% | -4.7% |
| Q2 2018 | $800,000 | -6.0% | 2,000,000 | 0.0% | 0.06% | +16.4% |
| Q1 2018 | $851,000 | +2.5% | 2,000,000 | 0.0% | 0.06% | +12.2% |
| Q4 2017 | $830,000 | -0.1% | 2,000,000 | 0.0% | 0.05% | +14.0% |
| Q3 2017 | $831,000 | +51.1% | 2,000,000 | 0.0% | 0.04% | +48.3% |
| Q2 2017 | $550,000 | 0.0% | 2,000,000 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $550,000 | +7.8% | 2,000,000 | 0.0% | 0.03% | +20.8% |
| Q4 2016 | $510,000 | -21.5% | 2,000,000 | 0.0% | 0.02% | -20.0% |
| Q3 2016 | $650,000 | +44.4% | 2,000,000 | 0.0% | 0.03% | +42.9% |
| Q2 2016 | $450,000 | – | 2,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 2,000,000 | $36,000 | 0.00% |
| Bruce & Co., Inc. | 2,000,000 | $10,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |